These two cases suggest that indels might be a new predictor of PD-1 blockade response for ICC patients beside PD-L1 expression, TMB, MSI, and dMMR, warranting further clinical investigation. The gene discussed is PDCD1; the disease is intrahepatic cholangiocarcinoma.